Camp4 Therapeutics Corporation
CAMP
$4.42
$0.020.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -82.91% | 54.50% | -166.80% | -19.96% | -1.24% |
| Total Depreciation and Amortization | -0.96% | 39.78% | -10.58% | -3.26% | 2.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 199.06% | -73.95% | 670.14% | 176.70% | -4.22% |
| Change in Net Operating Assets | -210.29% | -105.19% | 4,617.62% | -186.21% | 111.50% |
| Cash from Operations | -15.53% | -274.50% | 156.10% | -8.45% | 27.60% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 83.78% | -254.17% | 147.68% |
| Issuance of Common Stock | -92.98% | -99.77% | -23.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -75.88% | -- | -- |
| Cash from Financing | -92.98% | -99.80% | -39.67% | 65,711.11% | 147.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.27% | -131.32% | -3.66% | 452.48% | 30.21% |